Nifoxipam
| Nifoxipam | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 315.26 g/mol [1] |
| Predicted LogP | 1.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H10FN3O4 |
| IUPAC name | 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one |
| SMILES | C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)[N+](=O)[O-])O)F |
| InChI | InChI=1S/C15H10FN3O4/c16-11-4-2-1-3-9(11)13-10-7-8(19(22)23)5-6-12(10)17-14(20)15(21)18-13/h1-7,15,21H,(H,17,20) |
| InChIKey | UHFIFTRHLBAWGY-UHFFFAOYSA-N |
| CAS number | 74723-10-7 |
| UNII | 9O6C9M3CH6 |
| PubChem CID | 3058221 |
Nifoxipam (also known as Dp 370, 5-(2-Fluorophenyl)-1,3-dihydro-3-hydroxy-7-nitro-2H-1,4-benzodiazepin-2-one, 1,3-Dihydro-5-(2-fluorophenyl)-3-hydroxy-7-nitro-2H-1,4-benzodiazepin-2-one, 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(2-fluorophenyl)-3-hydroxy-7-nitro-, 2h-1,4-benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-7-nitro-, 5-(2-fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2h-1,4-benzodiazepin-2-one, 3-Hydroxy Nor-Flunitrazepam, 3-Hydroxy Nor-Flunitrazepam (Nifoxipam) (1.0 mg/mL in Methanol), Zca72310 or Ds-016880) is a substance of the aniline and benzodiazepine class.
Chemistry
Stereochemistry []
Nifoxipam is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Nifoxipam matches Lipinski's rule of five.Legal status []
- Australia: Nifoxipam is Unscheduled.
- Brazil: Nifoxipam is a B1.
- Canada: Nifoxipam is a Schedule IV.
- Germany: Nifoxipam is a Neuer psychoaktiver Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Nifoxipam is a PSA.
- United States: Nifoxipam is Unscheduled.
- United Nations: Nifoxipam is Unscheduled.
- Other: Nifoxipam is a In general legal for medical and research uses..
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3058221, Nifoxipam. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3058221
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Nifoxipam. UNII: 9O6C9M3CH6. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9O6C9M3CH6
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:00:43 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 18:00:39 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 18:00:39 |
| gsrs | ok | 2026-11-20 18:00:39 |
| hmdb | missing (no HMDB id) | 2026-11-20 18:00:39 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 18:00:42 |
| pubchem | ok | 2026-11-20 18:00:38 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:00:39 | |
| sider | missing (not in SIDER) | 2026-11-20 18:00:39 |
| structure | ok | 2026-11-20 18:00:39 |
| wikipedia | ok | 2026-11-20 18:00:39 |